首页> 外文期刊>Pfluegers Archiv: European Journal of Physiology >Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis
【24h】

Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis

机译:肠道微生物群和慢性肾病:证据和机制,在胃肠道肾轴上调解新的通信

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic kidney disease (CKD) represents a growing public health problem associated with loss of kidney function and cardiovascular disease (CVD), the main leading cause of morbidity and mortality in CKD. It is well established that CKD is associated with gut dysbiosis. Over the past few years, there has been a growing interest in studying the composition of the gut microbiota in patients with CKD as well as the mechanisms by which gut dysbiosis contributes to CKD progression, in order to identify possible therapeutic targets to improve the morbidity and survival in CKD. The purpose of this review is to explore the clinical evidence and the mechanisms involved in the gut-kidney crosstalk as well as the possible interventions to restore a normal balance of the gut microbiota in CKD. It is well known that the influence of the gut microbiota on the gut-kidney axis acts in a reciprocal way: on the one hand, CKD significantly modifies the composition and functions of the gut microbiota. On the other hand, gut microbiota is able to manipulate the processes leading to CKD onset and progression through inflammatory, endocrine, and neurologic pathways. Understanding the complex interaction between these two organs (gut microbiota and kidney) may provide novel nephroprotective interventions to prevent the progression of CKD by targeting the gut microbiota. The review is divided into three main sections: evidences from clinical studies about the existence of a gut microbiota dysbiosis in CKD; the complex mechanisms that explain the bidirectional relationship between CKD and gut dysbiosis; and reports regarding the effects of prebiotic, probiotic, and synbiotic supplementation to restore gut microbiota balance in CKD.
机译:慢性肾病(CKD)代表与肾功能丧失和心血管疾病(CVD)丧失的不断增长的公共卫生问题,是CKD中发病率和死亡率的主要原因。很好地建立了CKD与肠道脱泻病相关。在过去的几年里,对CKD患者的肠道微生物群的组成以及肠道失育症导致CKD进展有助于改善发病率可能的治疗目标,越来越兴趣生存在CKD中。本评价的目的是探讨肠肾串扰中涉及的临床证据和机制,以及可能干预措施,以恢复CKD中肠道微生物群的正常平衡。众所周知,肠道微生物对肠道轴上的影响以往复方式起作用:一方面,CKD显着改变肠道微生物酵母的组成和功能。另一方面,通过炎症,内分泌和神经系统途径可以操纵导致CKD发作和进展的过程。了解这两种器官(肠道微生物群和肾脏)之间的复杂相互作用可以提供新的肾红外选择性干预措施,以防止CKD的进展靶向肠道微生物。审查分为三个主要部分:关于CKD中肠道微生物症失育症存在的临床研究的证据;解释CKD与肠道脱泻之间双向关系的复杂机制;关于益生元,益生菌和协会补充在CKD中恢复肠道微生物的疗效的报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号